U.S. Markets open in 5 hrs 56 mins

Luminex Corp (LMNX) Files 10-K for the Fiscal Year Ended on December 31, 2018

- By insider

Luminex Corp (LMNX) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Luminex Corp develops, manufactures and sells proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries. Its products include MAGPIX, Luminex 100/200, and FLEXMAP 3D. Luminex Corp has a market cap of $1.16 billion; its shares were traded at around $26.03 with a P/E ratio of 61.95 and P/S ratio of 3.67. The dividend yield of Luminex Corp stocks is 0.91%. Luminex Corp had annual average EBITDA growth of 15.60% over the past ten years. GuruFocus rated Luminex Corp the business predictability rank of 3.5-star.

For the last quarter Luminex Corp reported a revenue of $81.1 million, compared with the revenue of $78.20 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $315.8 million, an increase of 3% from last year. For the last five years Luminex Corp had an average revenue growth rate of 8.9% a year.

The reported diluted earnings per share was 41 cents for the year, a decline of 38.8% from the previous year. Over the last five years Luminex Corp had an EPS growth rate of 7.2% a year. The Luminex Corp had an operating margin of 8.82%, compared with the operating margin of 12.12% a year before. The 10-year historical median operating margin of Luminex Corp is 10.02%. The profitability rank of the company is 7 (out of 10).

At the end of the fiscal year, Luminex Corp has the cash and cash equivalents of $76.4 million, compared with $127.1 million in the previous year. The company had no long term debt. Luminex Corp has a financial strength rank of 9 (out of 10).

At the current stock price of $26.03, Luminex Corp is traded at close to its historical median P/S valuation band of $27.61. The P/S ratio of the stock is 3.67, while the historical median P/S ratio is 3.87. The intrinsic value of the stock is $8.88 a share, according to GuruFocus DCF Calculator. The stock gained 32.24% during the past 12 months.

For the complete 20-year historical financial data of LMNX, click here.

This article first appeared on GuruFocus.